blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3618813

EP3618813 - IMPROVED EXTENDED RELEASE HIGHLY LOADED DRUG COMPOSITIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.05.2023
Database last updated on 14.09.2024
FormerThe patent has been granted
Status updated on  03.06.2022
FormerGrant of patent is intended
Status updated on  20.01.2022
FormerExamination is in progress
Status updated on  04.12.2020
FormerRequest for examination was made
Status updated on  07.02.2020
FormerThe international publication has been made
Status updated on  09.11.2018
Formerunknown
Status updated on  02.07.2018
Most recent event   Tooltip09.02.2024Lapse of the patent in a contracting state
New state(s): IT
published on 13.03.2024  [2024/11]
Applicant(s)For all designated states
Lubrizol Advanced Materials, Inc.
9911 Brecksville Road
Cleveland, OH 44141-3247 / US
[2020/11]
Inventor(s)01 / MIINEA, Liliana A.
9911 Brecksville Road
Cleveland, Ohio 44141-3247 / US
02 / DRAGANOIU, Elena S.
3700 Steeles Avenue West
Suite 201
Vaughan, Ontario L4L 8K8 / CA
03 / CHIKHALIKAR, Kedar V.
Application and Business Center
6th & 7th Floor
Jaswanti Landmark
Mehra Industrial Estate, LBS Marg, Vikhroli
Mumbai 400 079 / IN
04 / CHADAWAR, Vikrant V.
Application and Business Center
6th & 7th Floor
Jaswanti Landmark
Mehra Industrial Estate, LBS Marg, Vikhroli
Mumbai 400 079 / IN
 [2020/11]
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[2020/11]
Application number, filing date18725989.001.05.2018
[2020/11]
WO2018US30380
Priority number, dateUS201762500078P02.05.2017         Original published format: US 201762500078 P
[2020/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018204317
Date:08.11.2018
Language:EN
[2018/45]
Type: A1 Application with search report 
No.:EP3618813
Date:11.03.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 08.11.2018 takes the place of the publication of the European patent application.
[2020/11]
Type: B1 Patent specification 
No.:EP3618813
Date:06.07.2022
Language:EN
[2022/27]
Search report(s)International search report - published on:EP08.11.2018
ClassificationIPC:A61K9/20, A61K31/138, A61K31/155, A61K31/4015
[2020/11]
CPC:
A61K9/2027 (EP,IL,KR,US); A61K31/155 (EP,IL,KR,US); A61K31/4015 (EP,IL,KR,US);
A61K31/4458 (KR); A61K31/616 (KR); A61K9/2009 (KR);
A61K9/2054 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/11]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:VERBESSERTE WIRKSTOFFZUBEREITUNG MIT VERLANGSAMTER FREISETZUNG UND HOHER BELADUNG[2022/03]
English:IMPROVED EXTENDED RELEASE HIGHLY LOADED DRUG COMPOSITIONS[2020/11]
French:COMPOSITION AMELIOREE FORTEMENT CHARGEE AVEC UNE LIBERATION PROLONGEE[2022/03]
Former [2020/11]VERBESSERTE HOCHBELADENE ARZNEIZUSAMMENSETZUNGEN MIT VERLÄNGERTER FREISETZUNG
Former [2020/11]COMPOSITIONS DE MÉDICAMENT HAUTEMENT CHARGÉES À LIBÉRATION PROLONGÉE AMÉLIORÉES
Entry into regional phase18.11.2019National basic fee paid 
18.11.2019Designation fee(s) paid 
18.11.2019Examination fee paid 
Examination procedure22.02.2019Request for preliminary examination filed
International Preliminary Examining Authority: EP
18.11.2019Examination requested  [2020/11]
18.11.2019Date on which the examining division has become responsible
03.12.2020Despatch of a communication from the examining division (Time limit: M04)
12.04.2021Reply to a communication from the examining division
21.01.2022Communication of intention to grant the patent
05.05.2022Fee for grant paid
05.05.2022Fee for publishing/printing paid
05.05.2022Receipt of the translation of the claim(s)
Opposition(s)11.04.2023No opposition filed within time limit [2023/24]
Fees paidRenewal fee
27.05.2020Renewal fee patent year 03
27.05.2021Renewal fee patent year 04
27.05.2022Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL06.07.2022
AT06.07.2022
CZ06.07.2022
DK06.07.2022
EE06.07.2022
FI06.07.2022
HR06.07.2022
IT06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
[2024/11]
Former [2024/08]AL06.07.2022
AT06.07.2022
CZ06.07.2022
DK06.07.2022
EE06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/37]AL06.07.2022
AT06.07.2022
CZ06.07.2022
DK06.07.2022
EE06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/29]AL06.07.2022
AT06.07.2022
CZ06.07.2022
DK06.07.2022
EE06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SK06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/23]AT06.07.2022
CZ06.07.2022
DK06.07.2022
EE06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SK06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/22]AT06.07.2022
CZ06.07.2022
DK06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RO06.07.2022
RS06.07.2022
SE06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/21]DK06.07.2022
FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RS06.07.2022
SE06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/20]FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RS06.07.2022
SE06.07.2022
SM06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/12]FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RS06.07.2022
SE06.07.2022
NO06.10.2022
GR07.10.2022
IS06.11.2022
PT07.11.2022
Former [2023/11]FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
PL06.07.2022
RS06.07.2022
SE06.07.2022
NO06.10.2022
GR07.10.2022
PT07.11.2022
Former [2023/10]FI06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
RS06.07.2022
SE06.07.2022
NO06.10.2022
GR07.10.2022
PT07.11.2022
Former [2023/09]FI06.07.2022
LT06.07.2022
LV06.07.2022
NL06.07.2022
RS06.07.2022
SE06.07.2022
NO06.10.2022
PT07.11.2022
Former [2023/08]FI06.07.2022
LT06.07.2022
NL06.07.2022
RS06.07.2022
SE06.07.2022
NO06.10.2022
Former [2023/06]NL06.07.2022
Cited inInternational search[A]GB831897  (BRISTOL MYERS CO) [A] 1-16 * the whole document *;
 [A]US4664915  (SIMONIAN HOVSEP [US]) [A] 1-16* claims 1-6 *;
 [A]WO2004069234  (IPCA LAB LTD [IN], et al) [A] 1-16 * claim - *;
 [A]WO2006082523  (AUROBINDO PHARMA LTD [IN], et al) [A] 1-16 * claim - *;
 [X]WO2007002516  (SPHERICS INC [US], et al) [X] 1-16 * the whole document *;
 [A]EP1843761  (ALEMBIC LTD [IN]) [A] 1-16 * claim - *
ExaminationEP1843761
by applicantUS2798053
 US3915921
 US4267103
 US5288814
 US5349030
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.